AbbVie
Update in progressABBV (NYSE)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDrug Manufacturers - General
AbbVie is a research-based biopharmaceutical company that discovers, develops, manufactures, and markets medicines and therapies worldwide. Its portfolio includes Skyrizi, Rinvoq, Imbruvica, Venclexta, Elahere, Epkinly, Emrelis, Botox Cosmetic, Juvederm, Vraylar, Duodopa, Ubrelvy, Qulipta, Vyalev, Botox Therapeutic, Ozurdex, Lumigan/Ganfort, Alphagan/Combigan, Refresh/Optive, Xen, Durysta, Restasis, Mavyret, Creon, and Linzess/Constella. Based in North Chicago, IL, since 2012.
Company score
- Sentiment
- 2.53
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- -0.09
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 2.27
- Governance
- 0.66
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.79
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 1.66
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNYSE (NYQ)
- LocationUnited States
- CEOMr. Robert A. Michael CPA
- Founded2012
- Employees57,000
- Websitewww.abbvie.com
Identifiers
- ISINUS00287Y1091
- FIGIBBG0025Y4RY4
- LEIFR5LCKFTG8054YNNRU85
- CUSIP00287Y109
- CIK0001551152